T HE PATHOPHYSIOLOGY and treatment of acquired severe aplastic anemia (ASAA) has been the subject of recent reviews.'2 Whether idiopathic or idiosyncratic, ASAA is a "likely-to-be-fatal"
disease.3 However, it has long been recognized that some patients will recover spontaneously, and a few lucky ones may do so with surprisingly rapid restoration of hematopoiesis. 35 The inherent unpredictability of the natural course of this disorder has made evaluation of therapeutic efforts most difficult. In particular, the commonly used agents-steroids and androgenshave never been shown to be of value in a prospective study, and their toxic side effects can contribute to the patient's problems. 
